Skip to main content

Decode's Shares Up 6 Percent on Bank Upgrade

NEW YORK (GenomeWeb News) — Shares in Decode Genetics were up 5.7 percent, or $.22, at $4.09 after the stock was upgraded by an investment bank today.
 
Piper Jaffray upgraded the stock to “outperform” from “market perform.”
 
Decode posted a 17-percent spike in fourth-quarter revenues last week, as R&D spending rose 4 percent and loss increased 10 percent. 
 
Lehman Brothers responded last week by upgrading the stock to “equal-weight” from “underweight,” and the company’s share price rose 10 percent on Thursday.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.